Literature DB >> 3090723

Positive nitrogen balance with human growth hormone and hypocaloric intravenous feeding.

J M Manson, D W Wilmore.   

Abstract

Nitrogen equilibrium cannot be achieved in surgical patients without adequate nitrogen and calorie intake, frequently requiring central venous feedings. To investigate the hormonal environment under which nitrogen retention might be achieved during hypocaloric feedings, we administered peripheral vein nutrition with growth hormone (GH) to four healthy male patients. The intravenous diets provided 50% of estimated energy requirements (mean 566 kcal/m2/day) and adequate nitrogen (6 gm/m2/day). Each subject was studied for two 7-day periods; 10 mg of GH was given daily during one period and placebo during the other. Administration of GH decreased weight loss, caused retention of nitrogen, potassium, and phosphorus in amounts closely matching their proportions in skeletal muscle, and stimulated insulin production. GH also raised serum levels of free fatty acids and glycerol, increased urinary excretion of ketones, and favored fat oxidation in the postabsorptive state. Hyperinsulinemia and increased lipolysis and ketogenesis may augment the primary effects of GH. Further studies at adequate and approximately 30% of adequate calorie intake confirmed these findings. Maintenance of body protein with GH may allow improved nutritional care of catabolic patients that was previously unrecognized.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3090723

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  23 in total

1.  Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients.

Authors:  G Garibotto; A Barreca; R Russo; A Sofia; P Araghi; A Cesarone; M Malaspina; F Fiorini; F Minuto; A Tizianello
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

Review 2.  Growth hormone, 1988.

Authors:  M O Thorner; M L Vance
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

3.  Human growth hormone prevents the protein catabolic side effects of prednisone in humans.

Authors:  F F Horber; M W Haymond
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

4.  Anabolic effects of oxandrolone after severe burn.

Authors:  D W Hart; S E Wolf; P I Ramzy; D L Chinkes; R B Beauford; A A Ferrando; R R Wolfe; D N Herndon
Journal:  Ann Surg       Date:  2001-04       Impact factor: 12.969

5.  Exogenous growth hormone: effects on the catabolic response to surgically produced acute stress and on postoperative immune function.

Authors:  R Vara-Thorbeck; J A Guerrero; J Rosell; E Ruiz-Requena; J M Capitán
Journal:  World J Surg       Date:  1993 Jul-Aug       Impact factor: 3.352

6.  Growth hormone increases the bursting strength of colonic anastomoses. An experimental study in the rat.

Authors:  H Christensen; H Oxlund; S Laurberg
Journal:  Int J Colorectal Dis       Date:  1990-08       Impact factor: 2.571

7.  Metabolic effects of recombinant human growth hormone in patients receiving parenteral nutrition.

Authors:  T R Ziegler; L S Young; J M Manson; D W Wilmore
Journal:  Ann Surg       Date:  1988-07       Impact factor: 12.969

Review 8.  Renal effects of growth hormone. II. Electrolyte homeostasis and body composition.

Authors:  G D Ogle; A R Rosenberg; G Kainer
Journal:  Pediatr Nephrol       Date:  1992-09       Impact factor: 3.714

9.  Effect of growth hormone on tumor and host in an animal model.

Authors:  R F Wolf; B Ng; B Weksler; M Burt; M F Brennan
Journal:  Ann Surg Oncol       Date:  1994-07       Impact factor: 5.344

10.  Recombinant growth hormone enhances muscle myosin heavy-chain mRNA accumulation and amino acid accrual in humans.

Authors:  Y Fong; M Rosenbaum; K J Tracey; G Raman; D G Hesse; D E Matthews; R L Leibel; J M Gertner; D A Fischman; S F Lowry
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.